Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir.
Nelfinavir is a potent HIV-protease inhibitor with pleiotropic effects in cancer cells. Experimental studies connect its anti-cancer effects to the suppression of the Akt signaling pathway, but the actual molecular targets remain unknown. Using a structural proteome-wide off-target pipeline, which i...
Main Authors: | Li Xie, Thomas Evangelidis, Lei Xie, Philip E Bourne |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-04-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC3084228?pdf=render |
Similar Items
-
Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors.
by: Li Xie, et al.
Published: (2009-05-01) -
Spectrophometric Determination of Nelfinavir Mesylate
by: K. Vanitha Prakash, et al.
Published: (2006-01-01) -
The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir
by: Mahbuba R. Subeha, et al.
Published: (2020-11-01) -
Induction of Suicidal Erythrocyte Death by Nelfinavir
by: Rosi Bissinger, et al.
Published: (2015-05-01) -
Nelfinavir restricts A549 cell growth by inhibiting STAT3 signaling
by: Fangli He, et al.
Published: (2021-06-01)